Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

R. K. Fuller, L. Branchey, D. R. Brightwell, R. M. Derman, C. D. Emrick, F. L. Iber, K. E. James, R. B. Lacoursiere, K. K. Lee, I. Lowenstam and al. et

We conducted a controlled, blinded, multicenter study of disulfiram treatment of alcoholism in 605 men randomly assigned to 250 mg of disulfiram (202 men); 1 mg of disulfiram (204 men), a control for the threat of the disulfiram-ethanol reaction; or no disulfiram (199 men), a control for the counseling that all received. Bimonthly treatment assessments were done for one year. Relative/friend interviews and blood and urine ethanol analyses were used to corroborate patients' reports. There were no significant differences among the groups in total abstinence, time to first drink, employment, or social stability. Among the patients who drank and had a complete set of assessment interviews, those in the 250-mg disulfiram group reported significantly fewer drinking days (49.0 +/- 8.4) than those in the 1-mg (75.4 +/- 11.9) or the no-disulfiram (86.5 +/- 13.6) groups. There was a significant relationship between adherence to drug regimen and complete abstinence in all groups. We conclude that disulfiram may help reduce drinking frequency after relapse, but does not enhance counseling in aiding alcoholic patients to sustain continuous abstinence or delay the resumption of drinking.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Emerging approaches to managing alcohol dependence
SWIFT
Am J Health Syst Pharm 2007;64:S12-S22.
ABSTRACT | FULL TEXT  

Improving adherence in patients with alcohol dependence: A new role for pharmacists
Peterson
Am J Health Syst Pharm 2007;64:S23-S29.
ABSTRACT | FULL TEXT  

Psychotic Spectrum Disorders and Alcohol Abuse: A Review of Pharmacotherapeutic Strategies and a Report on the Effectiveness of Naltrexone and Disulfiram
Petrakis et al.
Schizophr Bull 2006;32:644-654.
ABSTRACT | FULL TEXT  

What works in alcohol use disorders?
Luty
Adv. Psychiatr. Treat. 2006;12:13-22.
ABSTRACT | FULL TEXT  

Anticraving Medications for Relapse Prevention: A Possible New Class of Psychoactive Medications
O'Brien
Am. J. Psychiatry 2005;162:1423-1431.
ABSTRACT | FULL TEXT  

Metabolism by N-Acetyltransferase 1 In Vitro and in Healthy Volunteers: A Prototype for Targeted Inhibition
Cantilena et al.
J Clin Pharmacol 2004;44:1405-1411.
ABSTRACT | FULL TEXT  

Efficacy of Disulfiram and Cognitive Behavior Therapy in Cocaine-Dependent Outpatients: A Randomized Placebo-Controlled Trial
Carroll et al.
Arch Gen Psychiatry 2004;61:264-272.
ABSTRACT | FULL TEXT  

Bridging the Gap: A Hybrid Model to Link Efficacy and Effectiveness Research in Substance Abuse Treatment
Carroll and Rounsaville
Psychiatr. Serv. 2003;54:333-339.
ABSTRACT | FULL TEXT  

Naltrexone in the Treatment of Alcohol Dependence
Krystal et al.
NEJM 2001;345:1734-1739.
ABSTRACT | FULL TEXT  

Eliciting the Low-Activity Aldehyde Dehydrogenase Asian Phenotype by an Antisense Mechanism Results in an Aversion to Ethanol
Garver et al.
J. Exp. Med. 2001;194:571-580.
ABSTRACT | FULL TEXT  

Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence: Efficacy of Contingency Management and Significant Other Involvement
Carroll et al.
Arch Gen Psychiatry 2001;58:755-761.
ABSTRACT | FULL TEXT  

Outpatient Management of Patients with Alcohol Problems
Fiellin et al.
ANN INTERN MED 2000;133:815-827.
ABSTRACT | FULL TEXT  

PHARMACOTHERAPY OF ALCOHOLISM: GAPS IN KNOWLEDGE AND OPPORTUNITIES FOR RESEARCH
Kranzler
Alcohol Alcohol 2000;35:537-547.
ABSTRACT | FULL TEXT  

PARADIGM TO TEST A DRUG-INDUCED AVERSION TO ETHANOL
Garver et al.
Alcohol Alcohol 2000;35:435-438.
ABSTRACT | FULL TEXT  

A Double-blind, Placebo-Controlled Study of Oral Nalmefene for Alcohol Dependence
Mason et al.
Arch Gen Psychiatry 1999;56:719-724.
ABSTRACT | FULL TEXT  

Drug Therapy for Alcohol Dependence
Swift
NEJM 1999;340:1482-1490.
FULL TEXT  

Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt et al.
JAMA 1999;281:1318-1325.
ABSTRACT | FULL TEXT  

Patients with Alcohol Problems
O'Connor and Schottenfeld
NEJM 1998;338:592-602.
FULL TEXT  

A Range of Research-Based Pharmacotherapies for Addiction
O'Brien
Science 1997;278:66-70.
ABSTRACT | FULL TEXT  

Progress in Psychiatry- Second of Two Parts
Michels and Marzuk
NEJM 1993;329:628-638.
FULL TEXT